[PDF][PDF] Chronic Myeloid Leukemia: Epidemiology, Diagnosis, Evaluation and Monitoring

S Abdul-Rahman, GA Hamid - researchgate.net
remissions in the majority of patients, the prevalence of CML … of the BCR-ABL1 fusion by
fluorescence in situ hybridization (FISH) on … a useful test for monitoring therapeutic responses. …

[HTML][HTML] … in Acute Myeloid Leukemia with CBFB-MYH11 Fusion Transcript: Focus on the Role of Molecular Measurable Residual Disease (MRD) Monitoring

A Talami, F Bettelli, V Pioli, D Giusti, A Gilioli… - Biomedicines, 2021 - mdpi.com
… to optimize post-remission monitoring and to define effective … as acute lymphoblastic or
chronic myeloid leukemia [64,65], … cytometry and fluorescence in situ hybridization examination …

Treatment-free remission in real-world chronic myeloid leukemia patients: insights from German hematology practices

J Dengler, H Tesch, K Jentsch-Ullrich, A Gerhardt… - Acta …, 2022 - karger.com
status at TKI discontinuation and at the time-point of data collection, time to discontinuation
of TKI, and monitoring … between monitoring intervals in TFR and long-term prognosis are …

Molecular Techniques in the Diagnosis and Monitoring of Acute and Chronic Leukaemias

HW Ip, WF Tang - Pathogenesis and Treatment of Leukemia, 2023 - Springer
… lymphoblastic leukaemias (ALL), chronic myeloid leukaemia (… karyotyping and fluorescence
in-situ hybridisation (FISH) for … of TKI therapy, termed treatment-free remission (TFR), in the …

[HTML][HTML] Chronic myeloid leukemia-from the Philadelphia chromosome to specific target drugs: A literature review

MM Sampaio, MLC Santos, HS Marques… - World journal of …, 2021 - ncbi.nlm.nih.gov
… BCR-ABL1 rearrangements require fluorescence in situ hybridization (FISH) analysis …
monitoring if BM cells are not obtained and/or for the definition of complete cytogenetic remission (…

A review on characterization of BCR–ABL transcript variants for molecular monitoring of chronic myeloid leukemia phenotypes

B Zenebe, H Nigussie, G Belay, N Seboka - Hematology, 2023 - Taylor & Francis
… CML patients can be diagnosed by either cytogenetic (standard or fluorescence in situ
hybridization) or molecular techniques. Polymerase Chain Reaction (PCR) being a rapid and …

[HTML][HTML] The present and future of measurable residual disease testing in acute myeloid leukemia

JS Blachly, RB Walter, CS Hourigan - Haematologica, 2022 - ncbi.nlm.nih.gov
… karyotypes, or fluorescent in-situ hybridization is limited to a … monitoring for relapse detection
after treatment, quantification of treatment response, identification of patients in remission

[PDF][PDF] Minimal residual disease monitoring in childhood Philadelphia-positive acute lymphoblastic leukemia: prognostic significance and correlation between …

J Li, A Lu, Y Gao, Y Wan, J Wang, J Zhang, T Hu… - …, 2020 - haematologica.org
… Two patients died in remission due to severe pneumonia, at 6.6 and … ::ABL1 by fluorescence
in situ hybridization in a patient with … and adolescents with chronic myeloid leukemia in blast …

[HTML][HTML] Real-time molecular monitoring in acute myeloid leukemia with circulating tumor DNA

D Thakral, R Gupta, RK Sahoo, P Verma… - Frontiers in Cell and …, 2020 - frontiersin.org
Monitoring these alterations may further guide strategies for maintenance of remission in the
long term… flow cytometry, cytogenetics, fluorescence in situ hybridization (FISH), and PCR or …

[HTML][HTML] Genomic mechanisms influencing outcome in chronic myeloid leukemia

A Fernandes, N Shanmuganathan, S Branford - Cancers, 2022 - mdpi.com
… In the 1990s, fluorescence in situ hybridization (FISH) techniques … The deletion status was
found to be an independent … -free remission due to lack of standardized monitoring; however, …